Introduction
Measurement of plasma Viral Load (VL) is the most reliable way to assess virological monitoring infection with Human Immunodeficiency Virus (HIV). It is frequently used in clinical setting for diagnosis and virological monitoring of patients on Antiretrovirals (ARVs) [1] . It is also used to evaluate the effect of the ARV treatment. It estimates the amount of virus in a given volume. It also determines the success or failure of Antiretroviral Treatment (ART) whose main objective is for the suppression of viral replication [2] [3] . Studies have shown that sites with VL monitoring have lower mortality and morbidity rates and better justification of changing to better lines of therapy than those using only CD4 T cells count monitoring [ The VL is an important tool for monitoring patients. It is therefore important to find a more affordable alternative to the evaluation of the VL. Hence the objective of this study is to implement an in-house Quantitative Real-Time PCR to assess the VL of HIV infected patients in Kinshasa.
Methodology

Framework
This study was conducted as a cross-sectional study in collaboration with different Centers for Treatment and Supported People Living with HIV (PLHIV) in the city of Kinshasa [6] . It was conducted from July 2013 to February 2014.
Patients
One hundred and fifty five (155) patients diagnosed serologically positive for HIV Type 1 and naive of Antiretroviral Treatment (ART) were included in the study. Patients were diagnosed positive for HIV in the respective centers of origin according to the protocol of the National Program for the Fight against HIV/AIDS and Sexually Transmitted Infections [7] . These were all patients eligible for ART in their centers as recommended by the World Health Organization (WHO) [2]. Participation was voluntary for patients in this study. All participants signed an informed consent before the start of sampling.
Blood Sampling
Five milliliter (5 ml) of blood were collected in a tube with EDTA anticoagulant from the vein in the crook of the elbow. The collected blood was centrifuged at 1000 g for 10 minutes to obtain a clear separation into 3 phases. One milliliter of plasma (supernatant) was transferred into a microtube previously labeled and stored at −20˚C before being transported to the laboratory of Molecular Biology, Faculty of Medicine for analysis.
Extraction and Amplification of RNA
The RNA extraction was made from 140 μl of plasma and 10 ul of the internal extraction control (RNA-050.vs1 Diagenode) using the QIAamp RNA Mini Kit QIAGEN ® kit for RNA extraction Laboratory of Molecular Biology [8] . The extracted samples were stored at −20˚C until use. Control has its primers and probes included in the kit (DIA-EIC/RNA(Cy5)-050 Diagenode) that give it a Ct value of ±28.5 for 10,000 TCID 50/ml.
After extraction, a Multiplex Quantitative Real Time PCR was carried out for determining the amount of proviral HIV DNA in samples ( Table 1 and Table 2 ) according to protocols previously described [9] - [11] [12] . Targeted viral amplification region is part of the Long Terminal Repeat (LTR), which is the region more or less constant and preserved the genome of HIV type 1 [9] [13]. The calibration curve was plotted with standard controls. The standards used to graph the curve are commercial plasmas previously quantified from 10 2 to 10 7 by increments of a logarithm of 10 (AcroMetrix Control Panel # 94-2013). The inclination is acceptable for curve included between −3.40 and −3.10 in accordance with the protocol applicable thermocycler 7500 Fast RealTime PCR System from Applied Biosystems (ABS) [12] , and between −3.60 and −2.90 according to the procedure of viral quantification Biocentric marketed by [14] .
Results
Serology
A total of 155 samples of different HIV-infected patients, treatment-naive and eligible for ARVs treatment were received for determination of Viral Load (VL) by a Quantitative Real-Time PCR between July 2013 and February 2014. All samples were previously diagnosed HIV positive with Rapid Diagnostic Tests (RDT) in the respective centers.
Sex and Age
Of the 155 patients, we have 63 men and 92 women, a sex ratio of 1.46:1. The age group most represented is that of 26 to 35 years with 44 patients (28.39%) followed by that of 46 -55 years (25.80%) and 18 -25 years (20.65%) ( Table 3) .
Viral Load
One hundred and fifty three (153) samples were successfully amplified according to the protocol, or 98.71% of amplification. The median and mean values of VL are respectively 301,052 copies/ml or 5.48 log 10 copies/ml and 2,940,665 copies/ml or 6.47 log 10 copies/ml ( Table 4) . The extreme values of VL are 0 and 88,849,472 copies/ml (0 and 7.95 log 10 ), respectively for the extreme lower and higher values ( Table 4) .
Discussion
This aim of the study was to implement and evaluate the feasibility of an in-house Quantitative Real-Time PCR for assessment of plasma HIV Viral Load. One hundred fifty-five (155) plasma samples were amplified to determine the amount of viral RNA. All samples were previously tested for HIV by Rapid Diagnostic Tests (RDT) in the respective centers of origin.
One hundred fifty-three (153) technique is therefore reliable with a detection rate higher than 95%. Of the two non-reactive samples, after investigation, one patient affirmed that he have been followed prior to another facility for more than a year where he used to pay for the ARVs. This would explain the change in treatment center without informing them of the transfer and an undetectable VL if properly taking his treatment. The second non-reactive sample could be a different type of HIV because this technic if specific for HIV type 1 group M [11] [15] . With a detection limit of less than 100 copies/ml, this technique is a sensitive and reliable tool for evaluation of VL [16] . One major advantage of this technique is that it can be reproduced on any other real-time thermal cycler that has been previously validated. It is not limited to one brand or model of machine. It is a versatile open technique that can be used on all platforms. The PCR can be run on any Real-Time thermal cycler that can observe the protocols of temperature and time. The low-tech, and the relative simplicity of the technique make it a reliable and affordable method of evaluation in countries with limited resources. However, although little laborious, it requires appropriate facilities and well equipped for each handling step, and micropipettes calibrated regularly.
Moreover, it can be adapted to the genetic diversity of the country especially as primers and probes can be adjusted as necessitated. It is flexible and can be shaped to meet the need of the genetic diversity of HIV in Africa.
The other advantage of this in-house technique is the cost of the examination. Compared to other commercial kits, the commercial version of this technique (Biocentric) is the least expensive method for the evaluation of VL for the PLHIV [9] [15] . It provides a commercial reagent price of less than 10 American dollars (USD) per test. This is cheaper than all other commercial tests on the market [9] [15] that approximate 50.00 USD in laboratories performing VL in Kinshasa [6] .
Conclusion
The results of Viral Loads allowed us to assess the feasibility of the Quantitative Real-Time PCR. This method is a simple, reliable and less expensive alternative mean for the diagnosis and virological monitoring of HIV patients on ARVs. The use of validated real-time PCR open systems technology should be recommended for monitoring patients in countries with limited resources.
